Myeloproliferative disease induced by leukemogenic Ptpn11 (Shp-2) phosphatase arises from hematopoietic stem cells

被引:0
|
作者
Xu, Dan
Wang, Siying
Yu, Wen-Mei
Chan, Gordon
Araki, Toshiyuki
Bunting, Kevin D.
Neel, Benjamin G.
Qu, Cheng-Kui
机构
关键词
D O I
10.1158/1538-7445.AM10-4296A
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4296A
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Loss of Ptpn11 (Shp2) drives satellite cells into quiescence
    Griger, Joscha
    Schneider, Robin
    Lahmann, Ines
    Schoewel, Verena
    Keller, Charles
    Spuler, Simone
    Nazare, Marc
    Birchmeier, Carmen
    ELIFE, 2017, 6
  • [22] Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase
    Ruess, Dietrich A.
    Heynen, Guus J.
    Ciecielski, Katrin J.
    Ai, Jiaoyu
    Berninger, Alexandra
    Kabacaoglu, Derya
    Goerguelue, Kivanc
    Dantes, Zahra
    Woermann, Sonja M.
    Diakopoulos, Kalliope N.
    Karpathaki, Angeliki F.
    Kowalska, Marlena
    Kaya-Aksoy, Ezgi
    Song, Liang
    van der Laan, Eveline A. Zeeuw
    Lopez-Alberca, Maria P.
    Nazare, Marc
    Reichert, Maximilian
    Saur, Dieter
    Erkan, Mert M.
    Hopt, Ulrich T.
    Sainz, Bruno, Jr.
    Birchmeier, Walter
    Schmid, Roland M.
    Lesina, Marina
    Alguel, Hana
    NATURE MEDICINE, 2018, 24 (07) : 954 - +
  • [23] A cellular target engagement assay for the characterization of SHP2 (PTPN11) phosphatase inhibitors
    Romero, Celeste
    Lambert, Lester J.
    Sheffler, Douglas J.
    De Backer, Laurent J. S.
    Raveendra-Panickar, Dhanya
    Celeridad, Maria
    Grotegut, Stefan
    Rodiles, Socorro
    Holleran, John
    Sergienko, Eduard
    Pasquale, Elena B.
    Cosford, Nicholas D. P.
    Tautz, Lutz
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (09) : 2601 - 2613
  • [24] Identification of Cryptotanshinone as an Inhibitor of Oncogenic Protein Tyrosine Phosphatase SHP2 (PTPN11)
    Liu, Wei
    Yu, Bing
    Xu, Gang
    Xu, Wei-Ren
    Loh, Mignon L.
    Tang, Li-Da
    Qu, Cheng-Kui
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (18) : 7212 - 7221
  • [25] Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase
    Dietrich A. Ruess
    Guus J. Heynen
    Katrin J. Ciecielski
    Jiaoyu Ai
    Alexandra Berninger
    Derya Kabacaoglu
    Kivanc Görgülü
    Zahra Dantes
    Sonja M. Wörmann
    Kalliope N. Diakopoulos
    Angeliki F. Karpathaki
    Marlena Kowalska
    Ezgi Kaya-Aksoy
    Liang Song
    Eveline A. Zeeuw van der Laan
    María P. López-Alberca
    Marc Nazaré
    Maximilian Reichert
    Dieter Saur
    Mert M. Erkan
    Ulrich T. Hopt
    Bruno Sainz
    Walter Birchmeier
    Roland M. Schmid
    Marina Lesina
    Hana Algül
    Nature Medicine, 2018, 24 : 954 - 960
  • [26] Noonan Syndrome/Leukemia-associated Gain-of-function Mutations in SHP-2 Phosphatase (PTPN11) Enhance Cell Migration and Angiogenesis
    Wang, Siying
    Yu, Wen-Mei
    Zhang, Wanming
    McCrae, Keith R.
    Neel, Benjamin G.
    Qu, Cheng-Kui
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (02) : 913 - 920
  • [27] Activating Mutations in Protein Tyrosine Phosphatase Ptpn11 (Shp2) Enhance Reactive Oxygen Species Production That Contributes to Myeloproliferative Disorder
    Xu, Dan
    Zheng, Hong
    Yu, Wen-Mei
    Qu, Cheng-Kui
    PLOS ONE, 2013, 8 (05):
  • [28] Study of SHP-2 (PTPN11) allosterism on structural movement using solution perturbed molecular dynamics simulation
    Li, Xiaobo
    Dong, Lei
    Xu, Weiren
    Bhuyan, Soumitra S.
    Chen, Chenglung
    Wang, Runling
    JOURNAL OF MOLECULAR LIQUIDS, 2016, 223 : 509 - 515
  • [29] The Mutation of the PTPN11 Gene that Encodes SHP-2 Protein Promotes Tumorigenic Activity of the NF1-Deficient cells.
    Arima, Y.
    Harigai, R.
    Saya, H.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [30] Association between serum pepsinogens and polymorphism of PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese
    Goto, Y
    Ando, T
    Yamamoto, K
    Tamakoshi, A
    El-Omar, E
    Goto, H
    Hamajima, N
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (01) : 203 - 208